Results 171 to 180 of about 150,466 (311)

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Evaluation of left ventricular systolic function in opium users by strain echocardiography. [PDF]

ESC Heart Fail
Mohammadi K, Habibi-Khorasani S, Nasri H, Toudeshki KK, Mirtajaddini M, Davari N.   +5 more
europepmc   +1 more source

Chronic Total Occlusion of the Left Main Coronary Artery With Preserved Left Ventricular Systolic Function Presenting as a Chronic Coronary Syndrome: A Case Report and Brief Review. [PDF]

Cureus, 2023
Aydın SŞ.
europepmc   +1 more source

Systolic left ventricular function improves more by beta-blokade than losartan: the life study [PDF]

, 2003
Kristian Wachtell
openalex   +1 more source

Assessment of left ventricular systolic function and pathological changes using layer-specific strain in rats with myocardial hypertrophy at various disease stages. [PDF]

Int J Cardiovasc Imaging
Cui L, Wang Q, Luo Q, Su X, Zhang J, Ding Y.   +5 more
europepmc   +1 more source

Left Ventricular Systolic Function After 3 Months of SGLT2 Inhibitor Therapy in Heart Failure Patients with Reduced Ejection Fraction. [PDF]

J Cardiovasc Transl Res, 2023
Mustapic I, Bakovic D, Susilovic-Grabovac Z, Borovac JA.   +3 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Heart Failure with Improved Ejection Fraction: Insight into the Variable Nature of Left Ventricular Systolic Function. [PDF]

Int J Environ Res Public Health, 2022
Wybraniec MT, Orszulak M, Męcka K, Mizia-Stec K.   +3 more
europepmc   +1 more source

112 The contribution of systolic left ventricular long-axis function for the detection of myocardial viability [PDF]

, 2003
Konstantina P. Bouki, Áthanasios Kranidis, G. Pavlakis, T KAKAVAS, Κωνσταντίνος Κωστόπουλος, J KARANGIS, T. Xydas, E. Papasteriadis   +7 more
openalex   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source